| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:01 UTC |
|---|
| HMDB ID | HMDB0015539 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Lopinavir |
|---|
| Description | Lopinavir is only found in individuals that have used or taken this drug. It is an antiretroviral of the protease inhibitor class. It is marketed by Abbott as Kaletra, a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.Lopinavir inhibits the HIV viral protease enzyme. This prevents cleavage of the gag-pol polyprotein and, therefore, improper viral assembly results. This subsequently results in non-infectious, immature viral particles. |
|---|
| Structure | CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1 InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Kaletra | HMDB | | ABT-378a-157378-0a-157378.0 | HMDB | | ABT-378 | HMDB | | LPV | HMDB | | 378, ABT | HMDB | | N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide | HMDB | | ABT 378 | HMDB |
|
|---|
| Chemical Formula | C37H48N4O5 |
|---|
| Average Molecular Weight | 628.8008 |
|---|
| Monoisotopic Molecular Weight | 628.362470666 |
|---|
| IUPAC Name | (2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide |
|---|
| Traditional Name | lopinavir |
|---|
| CAS Registry Number | 192725-17-0 |
|---|
| SMILES | CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 |
|---|
| InChI Key | KJHKTHWMRKYKJE-SUGCFTRWSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Valine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Valine or derivatives
- Amphetamine or derivatives
- Phenoxy compound
- Phenol ether
- M-xylene
- Xylene
- Alkyl aryl ether
- Pyrimidone
- Monocyclic benzene moiety
- 1,3-diazinane
- Fatty amide
- Fatty acyl
- N-acyl-amine
- Benzenoid
- Pyrimidine
- Secondary alcohol
- Secondary carboxylic acid amide
- Urea
- Carboxamide group
- Carbonic acid derivative
- Ether
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0019 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.51 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.8684 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.11 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 60.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3036.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 204.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 272.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 777.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 718.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 110.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1587.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 816.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2084.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 440.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 477.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 125.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 60.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Lopinavir,1TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C | 4774.8 | Semi standard non polar | 33892256 | | Lopinavir,1TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O | 4623.5 | Semi standard non polar | 33892256 | | Lopinavir,1TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C | 4710.0 | Semi standard non polar | 33892256 | | Lopinavir,1TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C | 4676.4 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C)[Si](C)(C)C | 4683.1 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C)[Si](C)(C)C | 4065.9 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C)[Si](C)(C)C | 6275.9 | Standard polar | 33892256 | | Lopinavir,2TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C | 4667.1 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C | 3988.2 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C | 6250.0 | Standard polar | 33892256 | | Lopinavir,2TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C | 4613.1 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C | 4076.3 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C | 6158.3 | Standard polar | 33892256 | | Lopinavir,2TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 4493.7 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 4148.8 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 6259.2 | Standard polar | 33892256 | | Lopinavir,2TMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 4547.7 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 4120.5 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C | 6262.8 | Standard polar | 33892256 | | Lopinavir,2TMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)[Si](C)(C)C | 4606.3 | Semi standard non polar | 33892256 | | Lopinavir,2TMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)[Si](C)(C)C | 4043.9 | Standard non polar | 33892256 | | Lopinavir,2TMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)[Si](C)(C)C | 6350.3 | Standard polar | 33892256 | | Lopinavir,3TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4628.6 | Semi standard non polar | 33892256 | | Lopinavir,3TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 4015.6 | Standard non polar | 33892256 | | Lopinavir,3TMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C)O[Si](C)(C)C)[Si](C)(C)C | 5965.6 | Standard polar | 33892256 | | Lopinavir,3TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C)[Si](C)(C)C | 4550.7 | Semi standard non polar | 33892256 | | Lopinavir,3TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C)[Si](C)(C)C | 4094.0 | Standard non polar | 33892256 | | Lopinavir,3TMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)O[Si](C)(C)C)[Si](C)(C)C | 5907.0 | Standard polar | 33892256 | | Lopinavir,3TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)O[Si](C)(C)C | 4556.6 | Semi standard non polar | 33892256 | | Lopinavir,3TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)O[Si](C)(C)C | 4075.7 | Standard non polar | 33892256 | | Lopinavir,3TMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)O[Si](C)(C)C | 5897.5 | Standard polar | 33892256 | | Lopinavir,3TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4478.1 | Semi standard non polar | 33892256 | | Lopinavir,3TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)[Si](C)(C)C | 4150.3 | Standard non polar | 33892256 | | Lopinavir,3TMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C)C1=O)[Si](C)(C)C)[Si](C)(C)C | 6004.1 | Standard polar | 33892256 | | Lopinavir,1TBDMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C(C)(C)C | 4986.8 | Semi standard non polar | 33892256 | | Lopinavir,1TBDMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O | 4871.0 | Semi standard non polar | 33892256 | | Lopinavir,1TBDMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C | 4898.2 | Semi standard non polar | 33892256 | | Lopinavir,1TBDMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C | 4859.1 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5050.7 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4373.1 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #1 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCNC1=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6208.9 | Standard polar | 33892256 | | Lopinavir,2TBDMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 5053.8 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 4313.2 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #2 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 6182.2 | Standard polar | 33892256 | | Lopinavir,2TBDMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)O[Si](C)(C)C(C)(C)C | 5040.8 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)O[Si](C)(C)C(C)(C)C | 4315.1 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #3 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)O[Si](C)(C)C(C)(C)C | 6119.1 | Standard polar | 33892256 | | Lopinavir,2TBDMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 4913.4 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 4359.1 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #4 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 6201.4 | Standard polar | 33892256 | | Lopinavir,2TBDMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 4971.0 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 4357.8 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #5 | CC1=CC=CC(C)=C1OCC(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCN([Si](C)(C)C(C)(C)C)C1=O)[Si](C)(C)C(C)(C)C | 6207.3 | Standard polar | 33892256 | | Lopinavir,2TBDMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4994.1 | Semi standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4351.2 | Standard non polar | 33892256 | | Lopinavir,2TBDMS,isomer #6 | CC1=CC=CC(C)=C1OCC(=O)N([C@@H](CC1=CC=CC=C1)[C@@H](O)C[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](C(C)C)N1CCCNC1=O)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 6260.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (Non-derivatized) - 70eV, Positive | splash10-0feu-6925370000-713b224b442e85bb346b | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lopinavir GC-MS ("Lopinavir,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-11-02 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir , positive-QTOF | splash10-0fb9-0119005000-e99616dc321beea979ae | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir , positive-QTOF | splash10-0532-1900601000-f85a252f1640f27563a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir 50V, Positive-QTOF | splash10-0a4i-0900000000-3578e2c32c774a6e323f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir 10V, Positive-QTOF | splash10-004j-0000309000-34a01a3fe1b7908567ab | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir 20V, Positive-QTOF | splash10-000t-0500900000-b26acb5f91e9e55a6be5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir 40V, Positive-QTOF | splash10-0a4i-0900000000-b4ad3519debd6ec50066 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lopinavir 30V, Positive-QTOF | splash10-053r-0900400000-81442626229760ffe413 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 10V, Positive-QTOF | splash10-03fs-0210908000-054ffc2d70c7a928ed3e | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 20V, Positive-QTOF | splash10-0bwa-0711911000-c9c5439ab7698ec8fd81 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 40V, Positive-QTOF | splash10-05ai-3940000000-e1de250134ecffc3ae81 | 2016-08-02 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 10V, Negative-QTOF | splash10-004i-1600309000-a5fe821e3d663cb11961 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 20V, Negative-QTOF | splash10-00dl-4900101000-49d4f32903902eae73e3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 40V, Negative-QTOF | splash10-0006-9400000000-2399e0947eb63c53c244 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 10V, Positive-QTOF | splash10-056r-0300659000-e86c051846f2ce85f44a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 20V, Positive-QTOF | splash10-0550-2900532000-9df9f0a93610394f84a1 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 40V, Positive-QTOF | splash10-052k-4900100000-fa68120128333a757135 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 10V, Negative-QTOF | splash10-004i-0712669000-93271ad3fea09b7fa458 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 20V, Negative-QTOF | splash10-0a4r-5603950000-6e950fa2e516bd0177a4 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lopinavir 40V, Negative-QTOF | splash10-01b9-5901100000-03be5213ed13f4696388 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|